Related Experiment Video

Updated: Aug 15, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
11:11

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

A non-viral vector for in vivo gene delivery

Laura Thomas

    The Lancet. Neurology
    |October 8, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
    06:33

    Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

    Published on: February 16, 2024

    Related Experiment Videos

    Last Updated: Aug 15, 2026

    Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
    11:11

    Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

    Published on: December 17, 2016

    Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
    06:33

    Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

    Published on: February 16, 2024

    Related Concept Videos

    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

    Articles linked to this work by shared authors, journal, and citation graph.

    Implementation and sustainability of hospital-based harm reduction delivery: a qualitative analysis.

    Harm reduction journal·2026

    Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage.

    Journal of neurochemistry·2026

    Charting the Course: A Study of Nurses' Satisfaction With EHRs Amid the Pandemic.

    Computers, informatics, nursing : CIN·2025

    Reliability of comprehensive echocardiography evaluation of patent ductus arteriosus among extremely preterm neonates across a national network: A prospective observational study.

    Journal of neonatal-perinatal medicine·2025

    New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma.

    Scientific reports·2025

    Demographics of Mothers Donating to a Nonprofit Human Milk Bank in Australia.

    Journal of paediatrics and child health·2025

    Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

    The Lancet. Neurology·2026

    Advances in chronic subdural haematoma management: beyond the burr hole.

    The Lancet. Neurology·2026

    Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

    The Lancet. Neurology·2026

    Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

    The Lancet. Neurology·2026

    Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.

    The Lancet. Neurology·2026

    Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.

    The Lancet. Neurology·2026

    Safety evaluation of the food enzyme endo-polygalacturonase from the non-genetically modified Aspergillus tubingensis strain SPG 10-1199.

    EFSA journal. European Food Safety Authority·2026

    Safety evaluation of a food enzyme containing arabinan endo-1,5-α-l-arabinanase and endo-polygalacturonase activities from the non-genetically modified Aspergillus tubingensis strain PX22-272.

    EFSA journal. European Food Safety Authority·2026

    Inactivation of Wild Poliovirus with β-Propiolactone.

    Vaccines·2026

    Global ethylene oxide uses in foods and considerations for food safety.

    Journal of public health policy·2026

    Safety evaluation of the food enzyme containing endo-polygalacturonase and pectinesterase activities from the non-genetically modified Aspergillus luchuensis strain AP2 903-6.

    EFSA journal. European Food Safety Authority·2026

    Safety evaluation of an extension of use of the food enzyme α-amylase from the non-genetically modified Bacillus amyloliquefaciens strain LMG-S 32676.

    EFSA journal. European Food Safety Authority·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us